These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30823969)

  • 41. What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?
    Sester M; Kampmann B
    Thorax; 2016 Jan; 71(1):3-4. PubMed ID: 26678433
    [No Abstract]   [Full Text] [Related]  

  • 42. Association of the level of IFN-γ produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting.
    Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F
    Int Immunol; 2012 Feb; 24(2):71-8. PubMed ID: 22298884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?
    Ruhwald M; Andersen PL
    Future Microbiol; 2016 Sep; 11():1101-4. PubMed ID: 27545599
    [No Abstract]   [Full Text] [Related]  

  • 44. Latent tuberculosis infection--Revisiting and revising concepts.
    Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
    Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan.
    Sun HY; Huang YW; Huang WC; Chang LY; Chan PC; Chuang YC; Ruan SY; Wang JY; Wang JT
    Tuberculosis (Edinb); 2018 Jul; 111():121-126. PubMed ID: 30029896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of the incidence of latent Mycobacterium tuberculosis infection among primary health care professionals in two Brazilian capitals.
    Lima OC; Souza FM; Prado TND; Andrade RLM; Maciel ELN
    J Bras Pneumol; 2020 Mar; 46(2):e20190201. PubMed ID: 32130334
    [No Abstract]   [Full Text] [Related]  

  • 47. From latent to patent: rethinking prediction of tuberculosis.
    Cobelens F; Kik S; Esmail H; Cirillo DM; Lienhardt C; Matteelli A
    Lancet Respir Med; 2017 Apr; 5(4):243-244. PubMed ID: 28017341
    [No Abstract]   [Full Text] [Related]  

  • 48. Identifying components for programmatic latent tuberculosis infection control in the European Union.
    Sandgren A; Vonk Noordegraaf-Schouten JM; Oordt-Speets AM; van Kessel GB; de Vlas SJ; van der Werf MJ
    Euro Surveill; 2016 Aug; 21(34):. PubMed ID: 27589214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Active and latent tuberculosis in prisoners in the Central-West Region of Brazil.
    Estevan AO; Oliveira SM; Croda J
    Rev Soc Bras Med Trop; 2013; 46(4):515-8. PubMed ID: 23904084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection.
    Houben RM; Crampin AC; Ndhlovu R; Sonnenberg P; Godfrey-Faussett P; Haas WH; Engelmann G; Lombard CJ; Wilkinson D; Bruchfeld J; Lockman S; Tappero J; Glynn JR
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):24-31. PubMed ID: 21276292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment.
    Mir Viladrich I; Daudén Tello E; Solano-López G; López Longo FJ; Taxonera Samso C; Sánchez Martínez P; Martínez Lacasa X; García Gasalla M; Dorca Sargatal J; Arias-Guillén M; García García JM
    Arch Bronconeumol; 2016 Jan; 52(1):36-45. PubMed ID: 26187708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies for management of latent tuberculosis in endemic settings: building evidence.
    Shakoor S; Hasan R
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):836. PubMed ID: 28786789
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.
    van Altena R; Duggirala S; Gröschel MI; van der Werf TS
    Curr Pharm Des; 2011; 17(27):2853-62. PubMed ID: 21834760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testing for latent tuberculosis infection using interferon gamma release assays in commercial sex workers at an outreach clinic in Birmingham.
    Daly R; Khatib N; Larkins A; Dedicoat M
    Int J STD AIDS; 2016 Jul; 27(8):676-9. PubMed ID: 26589629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing the management of children with latent tuberculosis infection.
    Venturini E; Tersigni C; Chiappini E; de Martino M; Galli L
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):341-349. PubMed ID: 28074660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of latent tuberculosis in migrants to Victoria.
    Flynn MG; Brown LK
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E578-83. PubMed ID: 26779730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Global Landscape of Tuberculosis Therapeutics.
    Tornheim JA; Dooley KE
    Annu Rev Med; 2019 Jan; 70():105-120. PubMed ID: 30403551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latent Mycobacterium tuberculosis Infection.
    Tam JK
    N Engl J Med; 2015 Sep; 373(12):1178-9. PubMed ID: 26376152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.